CNC vs. IDXX: Centene vs. IDEXX Laboratories Stock Comparison
How do Centene (CNC) and IDEXX Laboratories (IDXX) stack up? This page sets them side by side across company profile, performance and risk, profitability, growth, financial strength, dividends, and valuation, with selected fundamentals also measured against each stock's industry-group peers.
Company Profile
Centene (CNC) and IDEXX Laboratories (IDXX) both fall under the Health Care Equipment & Services industry group, but CNC is classified in Health Care Providers & Services while IDXX is classified in Health Care Equipment & Supplies.
| Profile Item | CNC | IDXX |
|---|---|---|
| Name | Centene Corp. | IDEXX Laboratories, Inc. |
| Country/Region | United States | United States |
| GICS Sector | Health Care | Health Care |
| GICS Industry Group | Health Care Equipment & Services | Health Care Equipment & Services |
| GICS Industry | Health Care Providers & Services | Health Care Equipment & Supplies |
| GICS Sub-Industry | Managed Health Care | Health Care Equipment |
| Market Capitalization | 34.53 billion USD | 53.26 billion USD |
| Currency | USD | USD |
| Exchange | NYSE | Nasdaq |
| Listing Date | December 13, 2001 | June 21, 1991 |
| Security Type | Common Stock | Common Stock |
Price Performance
Cumulative Growth
Trailing Returns
Calendar-Year Returns
Performance Metrics
| Metric | CNC | IDXX |
|---|---|---|
| Total Return (1Y) | 84.77% | -1.84% |
| Total Return (3Y, Annualized) | -0.97% | 18.42% |
| Total Return (5Y, Annualized) | -1.48% | 2.02% |
Risk Profile
Drawdown History
Return Distribution
Risk Metrics
| Metric | CNC | IDXX |
|---|---|---|
| Volatility (1Y, Annualized) | 46.34% | 37.02% |
| Beta (5Y) | 1.07 | 1.44 |
| Max Drawdown (5Y) | -74.07% | -50.91% |
| Avg. Volume (3M) | 4.63M | 564.80K |
Risk-Adjusted Performance
Risk-Return Positioning
Risk-Adjusted Metrics
| Metric | CNC | IDXX |
|---|---|---|
| Sharpe Ratio (1Y) | 1.74 | -0.17 |
| Sortino Ratio (1Y) | 2.71 | -0.28 |
Profitability
ROE (TTM)
IDEXX Laboratories (IDXX) at 68.93% clears its industry range for ROE, a sharper capital-efficiency signal than Centene (CNC) at 6.74%, which is closer to a typical peer reading.
CNC
Health Care Equipment & Services industry group
6.74%
- Max
- 47.61%
- Q3
- 14.36%
- CNC
- 6.74%
- Median
- 5.45%
- Q1
- -10.67%
- Min
- -47.01%
IDXX
Health Care Equipment & Services industry group
68.93%
- IDXX
- 68.93%
- Max
- 47.61%
- Q3
- 14.36%
- Median
- 5.45%
- Q1
- -10.67%
- Min
- -47.01%
Net Margin (TTM)
IDEXX Laboratories (IDXX) at 25.36% retains a top-quartile share of revenue as profit, ahead of Centene (CNC) at 0.81%, which keeps about the industry-typical share.
CNC
Health Care Equipment & Services industry group
0.81%
- Max
- 29.35%
- Q3
- 9.33%
- Median
- 2.18%
- CNC
- 0.81%
- Q1
- -6.29%
- Min
- -28.46%
IDXX
Health Care Equipment & Services industry group
25.36%
- Max
- 29.35%
- IDXX
- 25.36%
- Q3
- 9.33%
- Median
- 2.18%
- Q1
- -6.29%
- Min
- -28.46%
Operating Margin (TTM)
IDEXX Laboratories (IDXX) at 33.14% operates in the top operating margin quartile, ahead of Centene (CNC) at 0.74%, which runs around its industry’s norm.
CNC
Health Care Equipment & Services industry group
0.74%
- Max
- 35.43%
- Q3
- 14.14%
- Median
- 6.81%
- CNC
- 0.74%
- Q1
- -0.28%
- Min
- -16.29%
IDXX
Health Care Equipment & Services industry group
33.14%
- Max
- 35.43%
- IDXX
- 33.14%
- Q3
- 14.14%
- Median
- 6.81%
- Q1
- -0.28%
- Min
- -16.29%
Profitability Metrics
| Metric | CNC | IDXX |
|---|---|---|
| ROE (TTM) | 6.74% | 68.93% |
| ROA (TTM) | 2.68% | 26.70% |
| Net Margin (TTM) | 0.81% | 25.36% |
| Operating Margin (TTM) | 0.74% | 33.14% |
| Gross Margin (TTM) | 11.34% | 62.72% |
Growth
Revenue Growth
Both Centene (CNC) at 19.44% and IDEXX Laboratories (IDXX) at 10.42% land near their industries' usual revenue growth ranges, so top-line momentum looks broadly in line with peers on both sides.
EPS Growth
IDEXX Laboratories (IDXX) at 22.59% is around its peer norm for EPS growth, while Centene (CNC) at -314.42% falls below its industry range, a notably weak earnings reading.
Growth Metrics
| Metric | CNC | IDXX |
|---|---|---|
| Revenue Growth (YoY) | 19.44% | 10.42% |
| Revenue Growth (3Y CAGR) | 10.45% | 8.52% |
| EPS Growth (YoY) | -314.42% | 22.59% |
| EPS Growth (3Y CAGR) | -- | 17.66% |
Financial Strength
Current Ratio (MRQ)
Both Centene (CNC) at 1.16 and IDEXX Laboratories (IDXX) at 1.19 run current ratio in the tighter-liquidity quartile of industry peers, leaving thinner cushions against current liabilities than typical competitors.
CNC
Health Care Equipment & Services industry group
1.16
- Max
- 7.59
- Q3
- 4.00
- Median
- 1.98
- Q1
- 1.37
- CNC
- 1.16
- Min
- 0.30
IDXX
Health Care Equipment & Services industry group
1.19
- Max
- 7.59
- Q3
- 4.00
- Median
- 1.98
- Q1
- 1.37
- IDXX
- 1.19
- Min
- 0.30
Debt / Equity (MRQ)
Both Centene (CNC) at 0.70 and IDEXX Laboratories (IDXX) at 0.52 fund their balance sheets with roughly industry-typical debt-to-equity mixes.
CNC
Health Care Equipment & Services industry group
0.70
- Max
- 1.88
- Q3
- 0.91
- CNC
- 0.70
- Median
- 0.58
- Q1
- 0.16
- Min
- 0.00
IDXX
Health Care Equipment & Services industry group
0.52
- Max
- 1.88
- Q3
- 0.91
- Median
- 0.58
- IDXX
- 0.52
- Q1
- 0.16
- Min
- 0.00
Financial Strength Metrics
| Metric | CNC | IDXX |
|---|---|---|
| Current Ratio (MRQ) | 1.16 | 1.19 |
| Debt / Equity (MRQ) | 0.70 | 0.52 |
| Net Debt / EBITDA | -1.71 | 0.46 |
Dividends
Dividend Yield (TTM)
Neither Centene (CNC) nor IDEXX Laboratories (IDXX) pays a dividend this period — they may reinvest, use buybacks, or simply not return cash through dividends.
CNC
Health Care Equipment & Services industry group
0.00%
- CNC
- 0.00%
- Max
- 0.00%
- Q3
- 0.00%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
IDXX
Health Care Equipment & Services industry group
0.00%
- IDXX
- 0.00%
- Max
- 0.00%
- Q3
- 0.00%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
Dividend Payout Ratio (TTM)
Neither Centene (CNC) nor IDEXX Laboratories (IDXX) pays a dividend this period — they may reinvest, use buybacks, or simply not return cash through dividends.
CNC
Health Care Equipment & Services industry group
0.00%
- CNC
- 0.00%
- Max
- 0.00%
- Q3
- 0.00%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
IDXX
Health Care Equipment & Services industry group
0.00%
- IDXX
- 0.00%
- Max
- 0.00%
- Q3
- 0.00%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
Dividend Metrics
| Metric | CNC | IDXX |
|---|---|---|
| Dividend Yield (TTM) | 0.00% | 0.00% |
| Dividend Payout Ratio (TTM) | 0.00% | 0.00% |
Valuation
P/E Ratio (TTM)
Both Centene (CNC) at 23.97 and IDEXX Laboratories (IDXX) at 45.56 land around their industries’ usual P/E ratio levels — neither is getting a clear earnings-multiple discount or premium versus peers.
CNC
Health Care Equipment & Services industry group
23.97
- Max
- 80.41
- Q3
- 47.62
- Median
- 29.93
- CNC
- 23.97
- Q1
- 21.19
- Min
- 4.21
IDXX
Health Care Equipment & Services industry group
45.56
- Max
- 80.41
- Q3
- 47.62
- IDXX
- 45.56
- Median
- 29.93
- Q1
- 21.19
- Min
- 4.21
P/S Ratio (TTM)
Centene (CNC) at 0.19 sits in the cheaper P/S ratio quartile while IDEXX Laboratories (IDXX) at 11.42 prices above its industry range — a wide gap in sales valuation between them.
CNC
Health Care Equipment & Services industry group
0.19
- Max
- 8.80
- Q3
- 4.32
- Median
- 2.13
- Q1
- 1.10
- CNC
- 0.19
- Min
- 0.03
IDXX
Health Care Equipment & Services industry group
11.42
- IDXX
- 11.42
- Max
- 8.80
- Q3
- 4.32
- Median
- 2.13
- Q1
- 1.10
- Min
- 0.03
P/B Ratio (MRQ)
Centene (CNC) at 1.55 sits in the lower P/B ratio quartile relative to book while IDEXX Laboratories (IDXX) at 28.50 prices above its industry range — a wide valuation gap against assets.
CNC
Health Care Equipment & Services industry group
1.55
- Max
- 11.68
- Q3
- 6.12
- Median
- 3.00
- Q1
- 1.73
- CNC
- 1.55
- Min
- -1.31
IDXX
Health Care Equipment & Services industry group
28.50
- IDXX
- 28.50
- Max
- 11.68
- Q3
- 6.12
- Median
- 3.00
- Q1
- 1.73
- Min
- -1.31
Valuation Metrics
| Metric | CNC | IDXX |
|---|---|---|
| P/E Ratio (TTM) | 23.97 | 45.56 |
| P/S Ratio (TTM) | 0.19 | 11.42 |
| P/B Ratio (MRQ) | 1.55 | 28.50 |
| Free Cash Flow Yield (TTM) | 8.93% | 2.00% |